Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...

After 1 month of pegylated interferon therapy ... PCR tests were consistently negative and the patient tolerated the drug well with no adverse events. The dose of erythropoietin was increased ...

The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and ...

Motzer and colleagues present updated results from a multicenter, phase III trial of sunitinib versus interferon-α as first-line treatment for patients with metastatic renal-cell carcinoma.

The U.S. Food and Drug Administration (FDA) has accepted Sobi’s supplemental Biologics License Application (sBLA) for ...

Notable interferons companies such as Bayer AG ... 19 based on its most recent communications with the U.S. Food and Drug Administration (FDA). To read more about the latest highlights related ...

THE Special Investigating Unit (SIU) wants to recover R33.4m million paid to the Cuban government by the Department of Defence for the procurement of Interferon alfa-2b drug during the outbreak of ...